Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape
New therapies. New techniques. New modes of communication. With rapid advancements in both healthcare and digital communications, pharmaceutical marketers face ever-steeper challenges in capturing the attention of healthcare professionals (HCPs). Even as the
Physicians' View of the Industry Giants: Ranking the Top Pharma Companies
The pharmaceutical industry is constantly evolving, and the perceptions of healthcare professionals (HCPs) play a critical role in shaping the public's trust and acceptance of drugs.To understand how physicians perceive the top
Oncology Commercial Leadership: Top 5 Pharma Manufacturers
Success strategies of the leading oncology manufacturer repsMany factors contribute to the success of any oncology therapy, beginning with efficacy. Yet, widespread uptake relies on physician prescribing power—and oncologists’ willingness to wield
Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity
A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities
Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity
Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on
Rare is Everywhere: How 5 Lessons from Rare-disease Market Research Apply to Patient Segments in Common Diseases
The continued growth of personalized medicine and other treatment trends presents new challenges for market researchers. Within patient populations that were once considered relatively homogenous, new, smaller patient subgroups are being identified as
We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years.
Oncology sales forces are complex and nuanced. They carry multiple products and indications, often conveying multiple themes in the same interaction, given the breadth of indications a typical oncologist treats. As a result, an oncology interaction is a prioritization exercise...